These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 14654542

  • 1. PRL-3 expression in metastatic cancers.
    Bardelli A, Saha S, Sager JA, Romans KE, Xin B, Markowitz SD, Lengauer C, Velculescu VE, Kinzler KW, Vogelstein B.
    Clin Cancer Res; 2003 Nov 15; 9(15):5607-15. PubMed ID: 14654542
    [Abstract] [Full Text] [Related]

  • 2. A phosphatase associated with metastasis of colorectal cancer.
    Saha S, Bardelli A, Buckhaults P, Velculescu VE, Rago C, St Croix B, Romans KE, Choti MA, Lengauer C, Kinzler KW, Vogelstein B.
    Science; 2001 Nov 09; 294(5545):1343-6. PubMed ID: 11598267
    [Abstract] [Full Text] [Related]

  • 3. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
    Kato H, Semba S, Miskad UA, Seo Y, Kasuga M, Yokozaki H.
    Clin Cancer Res; 2004 Nov 01; 10(21):7318-28. PubMed ID: 15534108
    [Abstract] [Full Text] [Related]

  • 4. Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.
    Li J, Guo K, Koh VW, Tang JP, Gan BQ, Shi H, Li HX, Zeng Q.
    Clin Cancer Res; 2005 Mar 15; 11(6):2195-204. PubMed ID: 15788667
    [Abstract] [Full Text] [Related]

  • 5. PRL-3 phosphatase is implicated in ovarian cancer growth.
    Polato F, Codegoni A, Fruscio R, Perego P, Mangioni C, Saha S, Bardelli A, Broggini M.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6835-9. PubMed ID: 16203771
    [Abstract] [Full Text] [Related]

  • 6. Cancer research. New insights into metastasis.
    Marx J.
    Science; 2001 Oct 12; 294(5541):281-2. PubMed ID: 11598274
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PRL-3: a metastasis-associated phosphatase in search of a function.
    Bessette DC, Wong PC, Pallen CJ.
    Cells Tissues Organs; 2007 Oct 12; 185(1-3):232-6. PubMed ID: 17587829
    [Abstract] [Full Text] [Related]

  • 9. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases.
    Gotley DC, Reeder JA, Fawcett J, Walsh MD, Bates P, Simmons DL, Antalis TM.
    Oncogene; 1996 Aug 15; 13(4):787-95. PubMed ID: 8761300
    [Abstract] [Full Text] [Related]

  • 10. [Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma].
    Zhao GP, Zhou ZG, Lei WZ, Yu YY, Zheng XL, Gao HK.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May 15; 8(3):237-40. PubMed ID: 16167237
    [Abstract] [Full Text] [Related]

  • 11. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis.
    Hidaka S, Yasutake T, Takeshita H, Kondo M, Tsuji T, Nanashima A, Sawai T, Yamaguchi H, Nakagoe T, Ayabe H, Tagawa Y.
    Clin Cancer Res; 2000 Jul 15; 6(7):2712-7. PubMed ID: 10914715
    [Abstract] [Full Text] [Related]

  • 12. Specific enhanced expression of platelet-derived endothelial cell growth factor in submucosa of human colorectal cancer.
    Nozawa T, Enomoto T, Koshida Y, Sato Y, Kuranami M.
    Dis Colon Rectum; 2004 Dec 15; 47(12):2093-100. PubMed ID: 15657660
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of the human PRL-3 gene is associated with the metastasis of primary non-small cell lung cancer.
    Yamashita S, Masuda Y, Matsumoto K, Okumura Y, Matsuzaki H, Kurizaki T, Haga Y, Katafuchi S, Murayama T, Ikei S, Kawahara K.
    Ann Thorac Cardiovasc Surg; 2007 Aug 15; 13(4):236-9. PubMed ID: 17717498
    [Abstract] [Full Text] [Related]

  • 14. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ, Keller PJ, Cox AD.
    Cancer Res; 2006 Mar 15; 66(6):3153-61. PubMed ID: 16540666
    [Abstract] [Full Text] [Related]

  • 15. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
    Kong L, Li Q, Wang L, Liu Z, Sun T.
    Neuropathology; 2007 Dec 15; 27(6):516-21. PubMed ID: 18021371
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of 32-kDa laminin-binding protein mRNA in colon cancer tissues.
    Pei DP, Han Y, Narayan D, Herz D, Ravikumar TS.
    J Surg Res; 1996 Feb 15; 61(1):120-6. PubMed ID: 8769953
    [Abstract] [Full Text] [Related]

  • 18. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X, Quiros RM, Maxhimer JB, Jiang P, Marcinek R, Ain KB, Platt JL, Shen J, Gattuso P, Prinz RA.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [Abstract] [Full Text] [Related]

  • 19. Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1.
    Zeng Q, Hong W, Tan YH.
    Biochem Biophys Res Commun; 1998 Mar 17; 244(2):421-7. PubMed ID: 9514946
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of PRL-3 overexpression in early stages of colonic cancer.
    Xing X, Peng L, Qu L, Ren T, Dong B, Su X, Shou C.
    Histopathology; 2009 Feb 17; 54(3):309-18. PubMed ID: 19236507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.